THE EFFECT OF ANGIOTENSIN RECEPTOR BLOCKER, CANDESARTAN AND NONSELECTIVE BETA BLOCKER, PROPRANOLOL COMBINATION THERAPY IN REDUCTION OF PORTAL HYPERTENSION COMPARED TO PROPRANOLOL MONTHERAPY

被引：0
|
作者：
Kim, Moon Young [1 ]
Baik, Soon Koo [1 ]
Jeon, Hyo Keun [1 ]
Park, Hong Jun [1 ]
Kim, Young Ju [1 ]
Cho, Yong Kyun [2 ]
Lee, Woo Jin [2 ]
Jang, Jae Hyun [2 ]
Cheon, Gab Jin [3 ]
Kim, Young Don [3 ]
机构：
[1] Yonsei Univ, Wonju Coll Med, Wonju, South Korea
[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Kangneung Asan Hosp, Kangnung, South Korea
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1567
引用
收藏
页码：1070A / 1070A
页数：1
相关论文
共 50 条
  • [1] THE EFFECT OF ANGIOTENSIN RECEPTOR BLOCKER, CANDESARTAN AND NONSELECTIVE BETA BLOCKER, PROPRANOLOL COMBINATION THERAPY IN REDUCTION OF PORTAL HYPERTENSION COMPARED TO PROPRANOLOL MONTHERAPY
    Kim, M. Y.
    Baik, S. K.
    Won, C. S.
    Byun, J. W.
    Park, H. J.
    Choi, H. J.
    Park, S. Y.
    Kwon, Y. H.
    Cheon, G. J.
    Kim, Y. D.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S330 - S330
  • [2] Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
    Kim, Jae Hyun
    Kim, Jung Min
    Cho, Youn Zoo
    Na, Ji Hoon
    Kim, Hyun Sik
    Kim, Hyoun A.
    Kang, Hye Won
    Baik, Soon Koo
    Kwon, Sang Ok
    Cha, Seung Hwan
    Kim, Young Ju
    Kim, Moon Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (04) : 376 - 383
  • [3] Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
    Lee, Hyun Woong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (04) : 345 - 346
  • [4] Letter: practical considerations for nonselective beta-blocker therapy in portal hypertension
    Shanahan, William
    Clarke, Maeve
    Carolan, Eimear
    Ryan, John D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (12) : 1475 - 1476
  • [5] INFLUENCE OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR CILAZAPRIL, THE BETA-BLOCKER PROPRANOLOL AND THEIR COMBINATION ON HEMODYNAMICS IN HYPERTENSION
    BELZ, GG
    BREITHAUPT, K
    ERB, K
    KLEINBLOESEM, CH
    WOLF, GK
    JOURNAL OF HYPERTENSION, 1989, 7 (10) : 817 - 824
  • [6] Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension
    Skurk, T
    Lee, YM
    Nicuta-Rölfs, TO
    Haastert, B
    Wirth, A
    Hauner, H
    DIABETES OBESITY & METABOLISM, 2004, 6 (01): : 56 - 62
  • [7] The nonselective beta adrenergic blocker propranolol demonstrates therapeutic efficacy against hemagioendotheliomas and angiosarcomas
    Bryan, Brad A.
    ANGIOGENESIS, 2013, 16 (01) : 265 - 266
  • [8] Effect of calcium channel blocker in combination with an angiotensin II receptor blocker in Japanese patients with hypertension
    Saruta, Takao
    DRUGS, 2006, 66 : 19 - 21
  • [9] Combination therapy of angiotensin receptor blocker and aldosterone receptor blocker on cardiovascular remodeling
    Yoshiyama, M
    Omura, T
    Matsumoto, R
    Yoshikawa, J
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 46P - 46P
  • [10] PAPAVERINE ABOLISHES THE ATHEROGENIC EFFECT OF THE BETA-BLOCKER PROPRANOLOL
    ANDRIANOVA, IV
    REKHTER, MD
    TERTOV, VV
    ANDREEVA, ER
    MIRONOV, AA
    OREKHOV, AN
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1992, 113 (03) : 353 - 356
12345